ARCHIVES

Cell Therapeutics To Appeal FDA Decision on Pixantrone.

This article is from The Cancer Letter archive.

Vol. 36 No. 33 | September 17, 2010

Download PDF Visit The Full Archive

Related Articles

President Obama Signs Recalcitrant Cancer Bill

January 4, 2013

NCI Seeks 150 Advocates For Advice On Plans, Policies.

March 2, 2001

Northwestern’s Warren Kibbe Named Director of NCI CBIIT

June 26, 2013

FDA Lacks Resources To Deal With Onslaught Of New Cancer Drugs, Friedman Tells Agency

August 14, 1992

ODAC Recommendation for Pertuzumab Signals FDA’s Resolve In Granting Accelerated Approvals

September 20, 2013

2015: “A Challenge For Our Generation,” AACR Says

July 18, 2003